Related Experiment Video
Updated: Jul 5, 2026
13:27
Generation of Human CD40-activated B cells
Published on: October 16, 2009
RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells
1Department of Oncology, The Affiliated Drum Tower Hospital, Medical School of Naniing University and Clinical Cancer Institute of Nanjing University, Naniing, China.
European Journal of Cancer Care
|May 20, 2008
Summary
Hepatocellular carcinoma (HCC) immunotherapy shows promise using modified B cells loaded with cancer RNA to activate specific CD8+ T cells. These activated T cells can effectively kill liver cancer cells, offering a new treatment avenue.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge with limited curative treatment options.
- Cell-based immunotherapy, utilizing antigen-presenting cells (APCs) to stimulate T cell responses, offers a potential alternative for liver cancer treatment.
Purpose of the Study:
- To investigate the potential of CD40 ligand-activated B (CD40-B) cells, electroporated with total RNA from HepG2 hepatocellular carcinoma cells, as alternative APCs.
- To evaluate the capacity of these RNA-loaded CD40-B cells to induce specific CD8+ T cell responses against HCC.
Main Methods:
- Phenotypic analysis of CD40-B cells to assess their activation and co-stimulatory molecule expression.
- Co-culture of RNA-loaded CD40-B cells with autologous peripheral blood mononuclear cells (PBMCs).
- Analysis of T cell antigen specificity, focusing on interferon-gamma production and cytotoxic activity against HepG2 cells.
Main Results:
- CD40-B cells exhibited a polyclonal, highly activated phenotype with upregulated co-stimulatory molecules, indicating potent antigen-presenting capabilities.
- CD40-B cells electroporated with HepG2 total RNA successfully activated antigen-specific CD8+ T cells.
- The activated CD8+ T cells demonstrated a significant killing effect on HepG2 cancer cells.
Conclusions:
- Carcinoma cell-derived total RNA-electroporated CD40-B cells can serve as effective alternative APCs for inducing antigen-specific CD8+ T cell responses.
- This approach holds promise as a novel immunotherapy strategy for hepatocellular carcinoma.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...